José M. Miró - Concepedia

Author

José M. Miró

Also Known As

Bruno Hoen, Francesc Marco, J. M. Miro, Jose M Miro, Jose M Miró, Jose M. Miro, Jose M. Miró, José M. Miró, José M Miró, José M. Miró

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Universitat de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona Universitat Autònoma de Barcelona Hospital de Sant Pau

About

José M. Miró is an author at Universitat de Barcelona specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	675
2	Health Sciences	3	3	117
3	Public Health	2	2	78
4	Biology	1	1	29
5	Blood Transplantation	1	1	18

José M. Miró

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection Juan Carlos López Bernaldo de Quirós, José M. Miró, José M. Peña, New England Journal of Medicine	2001	205
Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis Lawrence P. Park, Vivian H. Chu, Gail Peterson, Journal of the American Heart Association	2016	199
Patients at Risk of Complications of<i>Staphylococcus aureus</i>Bloodstream Infection Ana del Rı́o, Carlos Cervera, Asunción Moreno, Clinical Infectious Diseases Antimicrobial SusceptibilityAntibioticsHealthcare-associated InfectionPatient SafetyStaphylococcus Aureus	2009	114
Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens Miriam J. Álvarez-Martínez, José M. Miró, María Eugenia Valls, Diagnostic Microbiology and Infectious Disease Molecular Diagnostic TechniquesReal-time PcrHistopathologyDiagnosisPathology	2006	104
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection Montserrat Plana, Felipe García, Teresa Gallart, AIDS	2000	92
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC) Adam Trickey, Margaret May, Philipp Schommers, Clinical Infectious Diseases	2017	88
Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users Esteban Ribera, José M. Miró, Emilia Barrot Cortés, Archives of Internal Medicine	1998	83
Infective Endocarditis in Patients on Chronic Hemodialysis Juan M. Pericàs, Jaume Llopis, María Jesús Jiménez‐Expósito, Journal of the American College of Cardiology HemodialysisMedicineKidney FailureInfective EndocarditisDialysis Therapy	2021	64
Effect of Vancomycin Minimal Inhibitory Concentration on the Outcome of Methicillin-Susceptible Staphylococcus aureus Endocarditis Carlos Cervera, Ximena Castañeda, Cristina García de la Mària, Clinical Infectious Diseases	2014	63
Outcome and Prognostic Factors in HIV-1–Infected Patients on Dialysis in the cART Era: a GESIDA/SEN Cohort Study Joan Carles Trullàs, Frederic Cofán, Guillermina Barril, JAIDS Journal of Acquired Immune Deficiency Syndromes	2011	60

Page 1